Phase i study of 2-amino-5-bromo-6-phenyl-4(3h)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients

A. Rios, D. A. Stringfellow, F. A. Fitzpatrick, S. B. Reele, G. D. Gutknecht, E. M. Hersh

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'Phase i study of 2-amino-5-bromo-6-phenyl-4(3h)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences